99mTc-3PRGD2

DRUG5 trials

Sponsors

Peking Union Medical College Hospital, First Affiliated Hospital of Fujian Medical University, Fifth Affiliated Hospital, Sun Yat-Sen University

Conditions

Breast CancerDiagnoses DiseaseEsophageal CancerLung CancerLymph Node MetastasesRheumatoid Arthritis

Early Phase 1

99mTc-3PRGD2 SPECT/CT in Lung Cancer Patients

Peking Union Medical College HospitalLung Cancer

Start: 2011-02-28End: 2017-12-31Target: 100Updated: 2017-04-07

99mTc-3PRGD2 SPECT/CT in Rheumatoid Arthritis Patients

CompletedNCT02723760

First Affiliated Hospital of Fujian Medical UniversityRheumatoid Arthritis

Start: 2015-11-30End: 2018-12-31Updated: 2023-09-21

99mTc-3PRGD2 SPECT/CT in Esophagus Cancer Patients

CompletedNCT02744729

First Affiliated Hospital of Fujian Medical UniversityEsophageal Cancer

Start: 2015-10-31End: 2017-01-31Updated: 2020-08-03

Unknown Phase

99mTc-3PRGD2 SPECT/CT in Breast Cancer Patients

CompletedNCT02742168

First Affiliated Hospital of Fujian Medical UniversityBreast Cancer

Start: 2016-01-31End: 2018-10-31Updated: 2020-08-03

99m Tc-3PRGD2 SPECT/CT Imaging in the Diagnosis of Lymph Node Metastasis of Esophageal Carcinoma

Fifth Affiliated Hospital, Sun Yat-Sen UniversityDiagnoses Disease, Esophageal Cancer, Lymph Node Metastases

Start: 2020-08-01End: 2021-12-31Target: 30Updated: 2020-08-07

Related Papers

Comparison of 99mTc-3PRGD2 Integrin Receptor Imaging with 99mTc-MDP Bone Scan in Diagnosis of Bone Metastasis in Patients with Lung Cancer: A Multicenter Study

PLoS ONE2014-10-2228 citations